Mater Research, The University of Queensland, South Brisbane, QLD, Australia.
World Diabetes Foundation, Bagsvaerd, Denmark.
Front Endocrinol (Lausanne). 2020 Dec 3;11:614533. doi: 10.3389/fendo.2020.614533. eCollection 2020.
Gestational diabetes mellitus (GDM) is the commonest medical complication of pregnancy. The association of GDM with immediate pregnancy complications including excess fetal growth and adiposity with subsequent risk of birth trauma and with hypertensive disorders of pregnancy is well recognized. However, the associations with wide ranges of longer-term health outcomes for mother and baby, including the lifetime risks of obesity, pre-diabetes, and diabetes and cardiovascular disease have received less attention and few health systems address these important issues in a systematic way. This article reviews historical and recent data regarding prediction of GDM using demographic, clinical, and biochemical parameters. We evaluate current and potential future diagnostic approaches designed to most effectively identify GDM and extend this analysis into a critical evaluation of lifestyle and nutritional/pharmacologic interventions designed to prevent the development of GDM. The general approach to management of GDM during pregnancy is then discussed and the major final focus of the article revolves around the importance of a GDM diagnosis as a future marker of the risk of non-communicable disease (NCD), in particular pre-diabetes, diabetes, and cardiovascular disease, both in mother and offspring.
妊娠期糖尿病(GDM)是妊娠最常见的医学并发症。GDM 与即刻妊娠并发症相关,包括胎儿过度生长和肥胖,进而增加分娩创伤和妊娠高血压疾病的风险,这已得到广泛认可。然而,其与母婴广泛的长期健康结局的关联,包括肥胖、糖尿病前期和糖尿病以及心血管疾病的终生风险,受到的关注较少,很少有卫生系统以系统的方式解决这些重要问题。本文回顾了使用人口统计学、临床和生化参数预测 GDM 的历史和最新数据。我们评估了当前和潜在的未来诊断方法,旨在最有效地识别 GDM,并将这种分析扩展到对生活方式和营养/药物干预的批判性评估,这些干预旨在预防 GDM 的发生。然后讨论了妊娠期 GDM 的一般管理方法,本文的主要重点是 GDM 诊断作为未来非传染性疾病(NCD)风险的标志物的重要性,特别是在母亲和后代中糖尿病前期、糖尿病和心血管疾病的风险。